Literature DB >> 15248093

Two cases of severe phototoxic reactions related to long-term outpatient treatment with voriconazole.

S J Vandecasteele1, E Van Wijngaerden, W E Peetermans.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15248093     DOI： 10.1007/s10096-004-1176-7

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN： 0934-9723            Impact factor:   3.267


× No keyword cloud information.
  6 in total

1.  Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever.

Authors:  Thomas J Walsh; Peter Pappas; Drew J Winston; Hillard M Lazarus; Finn Petersen; John Raffalli; Saul Yanovich; Patrick Stiff; Richard Greenberg; Gerald Donowitz; Mindy Schuster; Annette Reboli; John Wingard; Carola Arndt; John Reinhardt; Susan Hadley; Robert Finberg; Michél Laverdière; John Perfect; Gary Garber; Giuseppe Fioritoni; Eli Anaissie; Jeanette Lee
Journal:  N Engl J Med       Date:  2002-01-24       Impact factor: 91.245

2.  Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis.

Authors:  David W Denning; Patricia Ribaud; Noel Milpied; Denis Caillot; Raoul Herbrecht; Eckhard Thiel; Andrea Haas; Markus Ruhnke; Hartmut Lode
Journal:  Clin Infect Dis       Date:  2002-01-22       Impact factor: 9.079

3.  Muco-cutaneous retinoid-effects and facial erythema related to the novel triazole antifungal agent voriconazole.

Authors:  D W Denning; C E Griffiths
Journal:  Clin Exp Dermatol       Date:  2001-11       Impact factor: 3.470

Review 4.  Voriconazole: a new triazole antifungal agent.

Authors:  Leonard B Johnson; Carol A Kauffman
Journal:  Clin Infect Dis       Date:  2003-02-10       Impact factor: 9.079

5.  Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis.

Authors:  Raoul Herbrecht; David W Denning; Thomas F Patterson; John E Bennett; Reginald E Greene; Jörg-W Oestmann; Winfried V Kern; Kieren A Marr; Patricia Ribaud; Olivier Lortholary; Richard Sylvester; Robert H Rubin; John R Wingard; Paul Stark; Christine Durand; Denis Caillot; Eckhard Thiel; Pranatharthi H Chandrasekar; Michael R Hodges; Haran T Schlamm; Peter F Troke; Ben de Pauw
Journal:  N Engl J Med       Date:  2002-08-08       Impact factor: 91.245

Review 6.  Voriconazole.

Authors:  LilyAnn Jeu; Frank J Piacenti; Aleksandr G Lyakhovetskiy; Horatio B Fung
Journal:  Clin Ther       Date:  2003-05       Impact factor: 3.393
  6 in total
  6 in total

1.  Voriconazole-induced photosensitivity.

Authors:  Anurag N Malani; David M Aronoff
Journal:  Clin Med Res       Date:  2008-09-18

Review 2.  Pharmacokinetic/pharmacodynamic profile of voriconazole.

Authors:  Ursula Theuretzbacher; Franziska Ihle; Hartmut Derendorf
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

3.  Recurrent erythematous plaques on sun-exposed sites in an African American boy with chronic granulomatous disease.

Authors:  Mamina M Turegano; Chyi-Chia R Lee; Harry L Malech; Suk S De Ravin; Edward W Cowen; Isaac Brownell
Journal:  J Am Acad Dermatol       Date:  2014-03       Impact factor: 11.527

Review 4.  Voriconazole : a review of its use in the management of invasive fungal infections.

Authors:  Lesley J Scott; Dene Simpson
Journal:  Drugs       Date:  2007       Impact factor: 9.546

5.  Voriconazole-induced phototoxicity masquerading as chronic graft-versus-host disease of the skin in allogeneic hematopoietic cell transplant recipients.

Authors:  Asha R Patel; Maria L Turner; Kristin Baird; Juan Gea-Banacloche; Sandra Mitchell; Steven Z Pavletic; Barbara Wise; Edward W Cowen
Journal:  Biol Blood Marrow Transplant       Date:  2009-03       Impact factor: 5.742

6.  Clinical safety and tolerability issues in use of triazole derivatives in management of fungal infections.

Authors:  Dionissios Neofytos; Edina Avdic; Anna-Pelagia Magiorakos
Journal:  Drug Healthc Patient Saf       Date:  2010-04-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.